Amundi Amphastar Pharmaceuticals, Inc. Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Amundi holds 14,925 shares of AMPH stock, worth $377,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,925
Previous 19,583
23.79%
Holding current value
$377,005
Previous $727,000
40.58%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$150 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...